Dashboard
1
Poor Management Efficiency with a low ROCE of 8.34%
- The company has been able to generate a Return on Capital Employed (avg) of 8.34% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Flat results in Sep 25
4
With ROE of 13.24%, it has a very attractive valuation with a 2.89 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.45%
0%
2.45%
6 Months
-18.77%
0%
-18.77%
1 Year
-1.18%
0%
-1.18%
2 Years
-26.09%
0%
-26.09%
3 Years
-23.75%
0%
-23.75%
4 Years
7.08%
0%
7.08%
5 Years
115.27%
0%
115.27%
Dallah Healthcare Co. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
25.27%
EBIT Growth (5y)
35.02%
EBIT to Interest (avg)
5.79
Debt to EBITDA (avg)
3.71
Net Debt to Equity (avg)
0.72
Sales to Capital Employed (avg)
0.55
Tax Ratio
3.87%
Dividend Payout Ratio
37.60%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.34%
ROE (avg)
11.48%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
2.89
EV to EBIT
27.66
EV to EBITDA
19.70
EV to Capital Employed
2.00
EV to Sales
3.78
PEG Ratio
3.05
Dividend Yield
1.33%
ROCE (Latest)
7.24%
ROE (Latest)
13.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
1,110.40
808.80
37.29%
Operating Profit (PBDIT) excl Other Income
201.90
143.80
40.40%
Interest
57.20
24.60
132.52%
Exceptional Items
0.00
0.00
Consolidate Net Profit
111.40
102.40
8.79%
Operating Profit Margin (Excl OI)
125.90%
133.50%
-0.76%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 37.29% vs 0.35% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 8.79% vs -12.10% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
4,066.90
3,205.70
26.86%
Operating Profit (PBDIT) excl Other Income
783.50
683.70
14.60%
Interest
150.50
107.80
39.61%
Exceptional Items
51.40
0.00
Consolidate Net Profit
540.50
485.20
11.40%
Operating Profit Margin (Excl OI)
137.40%
169.40%
-3.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 26.86% vs 8.93% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 11.40% vs 25.90% in Dec 2024
About Dallah Healthcare Co. 
Dallah Healthcare Co.
Hospital
No Details Available.
Company Coordinates 
No Company Details Available






